EGFR and neoplasm: For example, sialyltransferase inhibition was effective in reducing tumor cell loads in xenografted models using SCID or CD89 transgenic SCID mice treated with anti-EGFR IgG1, -IgG2 or -IgA2 antibodies (29, 47).